Medical Health & Life Science Research News

Canada DNA Vaccine Market interpreted by a new report

Medical and Health

Canada DNA Vaccine Market Size, Share & Trends Analysis Report by Type (Animal DNA Vaccine and Human DNA Vaccine) By Technology (Plasmid DNA Vaccine and Plasmid DNA Delivery) By Application (Oncology, Infectious Disease, and Others) Forecast period (2019-2025)

Canada DNA Vaccine market is anticipated to grow at a CAGR 41.6% during the forecast period. There are various factors driving the growth of the DNA vaccination market in Canada.

This includes increasing healthcare expenditure, investment by cancer research organizations and increasing prevalence of cancer. In May 2017, Canadian Gary kobinger has set to overcome the Zika virus by developing a DNA vaccine.

Mice are used in the earlier test of the vaccine. Moreover, the experimental vaccine referred to as GLS-5700, protected all the mice from brain damage, zika infection and death.

The vaccine also triggered a robust immune response in the monkeys. The vaccine is also expected to protect the child of pregnant women from Zika infection as well as protect it from microcephaly. 


The key market player that is active in the market includes Arbutus Biopharma Corp., Dendreon Pharmaceuticals LLC, GE Healthcare, GlaxoSmithKline PLC., Green Cross Corp., Innovio Biomedical Corp., Immunomic Therapeutics, Merck & Co., Pfizer Inc., Protein Sciences Corp., and Sanofi Inc. among other.

Apart from this, Dr. Weiner, specialized in DNA vaccines along with Dr. Kobinger has led the development of Ebola drug ZMapp at the National Microbiology Laboratory in Winnipeg.

It is under phase 1 human trials regarding DNA vaccines for MERS and Ebola. Likewise, the studies for HIV have also conducted by Gary Kobinger at Canada's National Microbiology Laboratory in Winnipeg.

It shows a high focus on R&D for DNA vaccination in Canada, which may result in widening the possibilities of the Canada DNA vaccination market for the effective treatment of several diseases.  


Furthermore, an increased prevalence of cancer is also expected to augment the Canada DNA vaccination market. According to the Canadian Cancer Statistics, it was estimated that around 1 in 2 Canadian will have cancer in a lifetime.

On the other hand, 1 out of 4 will have mortality due to cancer.

Market Segmentation

Canada DNA Vaccine Market by Type

  • Animal DNA Vaccine
  • Human DNA Vaccine

Canada DNA Vaccine Market by Technology

  • Plasmid DNA Vaccine 
  • Plasmid DNA Delivery 

Canada DNA Vaccine Market by Application

  • Oncology
  • Infectious Disease
  • Others


News From

Orion Market Research Pvt. Ltd.Orion Market Research Pvt. Ltd.
Category: Market Research Publishers and RetailersCompany about: Orion Market Research (OMR) is a market research company that endeavors to provide an exclusive blend of qualitative and quantitative market research reports to global clients. The company provides syndicate, customized market research report for over 20 business domains to customers across the globe. These reports provide valuable market insights to global clients in understanding the market trends and taking crucial business decisions. The company is serving global Fortune 500 companies, ...
This email address is being protected from spambots. You need JavaScript enabled to view it.